About Redona Therapeutics
Redona Therapeutics is a private company based in Watertown, Massachusetts. It has reported $66,779,837 raised in two offerings on Form D since September 2018. Its chief executive is Kazumi Shiosaki.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 21, 2023 | Jul 31, 2023 | $5,953,898of $11.9M target | 8 | $744K | DebtRule 506(b) | Form D ↗ |
| Aug 22, 2018 | Sep 6, 2018amended Jul 31, 2023 | $60,825,939of $76.9M target | 11 | $5.5M | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Total, two offerings | $66,779,837 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Redona Therapeutics's Form D filed Jul 31, 2023.
KS
Kazumi Shiosaki
President and Chief Executive Officer, director
HR
Henrijette Richter
Director
MS
Michal Silverberg
Director
CB
Christine Brennan
Director
LE
Luke Evnin
Director